Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ120112030,08
KB10041005-1,18
PKN74,3174,33-1,20
Msft464,15464,180,07
Nokia4,7314,736-0,25
IBM265266,30,03
Mercedes-Benz Group AG51,4351,45-0,23
PFE23,4523,460,29
05.06.2025 14:44:33
Indexy online
AD Index online
select
AD Index online
 

  • 05.06.2025 14:16:29
MLP AG (MLPG.DE, Xetra)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
8,24 0,12 0,01 345 073
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.06.2025
Popis společnosti

Business Summary: MLP SE is a Germany-based holding company engaged in the investment management and fund operators industries. Through its subsidiaries, the Company operates as a financial services company which offers financial products and solutions. The Company operates four business segments. The Financial Services segment provides consulting services, insurance, investments, pension provision schemes and loans, as well as contract brokering concerning these financial services, among others. In addition, this segment includes portfolio management, trustee credit business and credit card business. The Feri segment covers wealth and investment consulting. The Holding business segment covers the Company’s internal services and activities. The Non-Life Insurance segment covers underwriting. All segments are active in Germany, whereas the Feri segment also operates in Luxembourg. The Company operates MLP Finanzdienstleistungen AG, FERI AG, TPC GmbH and the DOMCURA Group as wholly owned subsidiaries.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, MLP SE revenues increased 10% to EUR1.07B. Net income increased 43% to EUR69.3M. Revenues reflect Holdings segment increase of 16% to EUR18.8M, DOMCURA segment increase of 31% to EUR4M. Net income benefited from Real estate development expenses decrease of 73% to EUR5.1M (expense), Inventory changes decrease of 62% to EUR4.3M (expense). Dividend per share increased from EUR0.30 to EUR0.36.



  • Poslední aktualizace: 05.06.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the Supervisory BoardMichael Kleinemeier6713.02.202413.02.2024
Chairman of the Executive Board, Chief Executive OfficerBelen Garijo6401.05.202101.01.2015
Vice Chairman of the Supervisory BoardSascha Held4228.05.202028.05.2020
Chief Financial Officer, Member of the Executive BoardHelene Von Roeder5301.07.202301.07.2023
Chief People OfficerKhadija Hammada-18.02.202518.02.2025
Head of Investor RelationsFlorian Schraeder-
Member of the Executive Board, Chief Executive Officer - Pharmaceuticals DivisionDanny Bar-zohar-
Member of the Executive Board, Chief Executive Officer - ElectronicsKai Beckmann5801.04.2011
Member of the Executive Board, Chief Executive Officer - the Life Science unitJean-charles Wirth-18.02.202518.02.2025